Arthroscopic shaver safety review
This article was originally published in The Gray Sheet
FDA is encouraging surgical facilities to evaluate the adequacy of their cleaning procedures for arthroscopic shavers after becoming aware of instances where pieces of tissue remain within shavers after cleaning in accordance with manufacturer instructions. Retained tissue can compromise the sterilization process for the devices, which are used for tissue resection and bone debridement. The agency advises hospitals to be sure that all personnel responsible for cleaning the products comply with the manufacturer's instructions, carefully inspect the devices following cleaning, and report any problems with retained tissue in arthroscopic shavers through FDA's MedWatch safety and adverse event reporting system. In the July MedSun newsletter, the agency notes that the hospital that brought the problem to its attention is effectively inspecting its shavers after cleaning by looking at the channels of the shaver hand piece with a 3 mm scope
You may also be interested in...
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.
Strong top-line efficacy in pyruvate kinase deficiency patients who don’t receive regular transfusions looks approvable, analysts say, but Agios will await data in regularly transfused patients.